Boxer Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-600,000
| Closed | -$23.6M | – | 61 |
|
|
2024
Q3 | $23.6M | Hold |
600,000
| – | – | 1.16% | 24 |
|
|
2024
Q2 | $23.4M | Hold |
600,000
| – | – | 1.23% | 25 |
|
|
2024
Q1 | $25.8M | Hold |
600,000
| – | – | 1.28% | 23 |
|
|
2023
Q4 | $27.6M | Hold |
600,000
| – | – | 1.38% | 23 |
|
|
2023
Q3 | $20.5M | Hold |
600,000
| – | – | 1.09% | 31 |
|
|
2023
Q2 | $23.1M | Hold |
600,000
| – | – | 1.07% | 33 |
|
|
2023
Q1 | $21.5M | Hold |
600,000
| – | – | 1.05% | 32 |
|
|
2022
Q4 | $23.7M | Hold |
600,000
| – | – | 1.25% | 30 |
|
|
2022
Q3 | $21.7M | Hold |
600,000
| – | – | 1.22% | 30 |
|
|
2022
Q2 | $18.3M | Hold |
600,000
| – | – | 1.16% | 30 |
|
|
2022
Q1 | $18.3M | Hold |
600,000
| – | – | 0.94% | 34 |
|
|
2021
Q4 | $18.7M | Sell |
600,000
-257,000
| -30% | -$8.03M | 0.73% | 31 |
|
|
2021
Q3 | $13.1M | Hold |
857,000
| – | – | 0.46% | 55 |
|
|
2021
Q2 | $16M | Buy |
+857,000
| New | +$16M | 0.56% | 54 |
|
|
2020
Q4 | – | Sell |
-600,000
| Closed | -$6.64M | – | 86 |
|
|
2020
Q3 | $6.64M | Hold |
600,000
| – | – | 0.23% | 62 |
|
|
2020
Q2 | $7.52M | Hold |
600,000
| – | – | 0.33% | 50 |
|
|
2020
Q1 | $6.8M | Buy |
+600,000
| New | +$6.8M | 0.46% | 45 |
|
|
2018
Q4 | – | Sell |
-300,000
| Closed | -$3.96M | – | 27 |
|
|
2018
Q3 | $3.96M | Buy |
+300,000
| New | +$3.96M | 0.44% | 21 |
|